Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 1388

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1A
Chunk 1388
---
 U.S. and global markets have been experiencing and are continuing to experience extreme volatility and disruptions in the
capital and credit markets and commodity prices due to rising inflation and interest rates, geopolitical tensions such as the conflict
between Russia and Ukraine and the armed conflict in Israel and Gaza, and other macroeconomic factors. A severe or prolonged economic
downturn, such as the current macroeconomic environment, could result in a variety of risks to our business, including, our ability to
raise additional capital when needed on acceptable terms, if at all. A weak or declining economy could also strain our suppliers of raw
materials used to manufacture our product candidates for our clinical trials, possibly resulting in supply disruption. Furthermore, our
stock price may decline due in part to the volatility of the stock market and any general economic downturn.

Changes
in tax law and regulations could adversely affect our business, financial condition and results of operations.

New
income, sales, use or other tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could affect the
tax treatment of any of our future earnings. Further, existing tax laws, statutes, rules, regulations or ordinances could be interpreted,
changed, modified or applied adversely to us. Generally, future changes in applicable tax laws and regulations, or their interpretation
and application, potentially with retroactive effect, could have an adverse effect on our business, financial condition and results of
operations. We are unable to predict whether such changes will occur and, if so, the ultimate impact on our business. We urge investors
to consult with their legal and tax advisers regarding the implications of potential changes in tax laws on an investment in our common
stock.

Item
1B. Unresolved Staff Comments.

We
do not have any unresolved comments issued by the SEC staff.

Item
1C. Cybersecurity

Cybersecurity
Risk Management and Strategy

We,
through our third party service provider that manages our information technology systems and networks, have developed and implemented
a cybersecurity risk management program intended to protect the confidentiality, integrity, and availability of our critical systems
and information. Our cybersecurity risk management program includes a cybersecurity incident response plan.

    61

We
design and assess our program based on the National Institute of Standards and Technology Cybersecurity Framework (NIST CSF). This does
not imply that we meet any particular technical standards, specifications, or requirements, only that we use the NIST CSF as a guide
to help us identify, assess, and manage cybersecurity